CORVUS PHARMACEUTICALS INC's ticker is and the CUSIP is 221015900. A total of 3 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | -67.3% | 11,000 | -49.1% | 0.00% | – |
| Q2 2023 | $49 | – | 21,600 | +2600.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 800 | -92.7% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 11,000 | +6.8% | 0.00% | – |
| Q3 2022 | $8,000 | – | 10,300 | +1616.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 600 | -83.8% | 0.00% | – |
| Q1 2022 | $6,000 | -93.3% | 3,700 | -90.1% | 0.00% | – |
| Q4 2021 | $90,000 | +462.5% | 37,400 | +513.1% | 0.00% | – |
| Q3 2021 | $16,000 | 0.0% | 6,100 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | +220.0% | 6,100 | +35782.4% | 0.00% | – |
| Q1 2021 | $5,000 | -96.4% | 17 | -95.6% | 0.00% | – |
| Q4 2020 | $137,000 | +1422.2% | 386 | +1508.3% | 0.00% | – |
| Q3 2020 | $9,000 | – | 24 | +2300.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 1 | -96.7% | 0.00% | – |
| Q4 2019 | $16,000 | – | 30 | +500.0% | 0.00% | – |
| Q3 2019 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 27,100 | $22,000 | 0.00% |
| SIMPLEX TRADING, LLC | 10,300 | $8,000 | 0.00% |